Prof. Badria got his B. Sc. in Pharmaceutical Sciences, Mansoura University, Egypt, Two M. Sc. In Pharmacognosy (Chemistry of Natural Products), Mansoura University, Egypt and M. Sc. In Pharmacognosy (Pharm. Cell Biology), University of Minnesota, USA and Ph.D in Pharmacognosy (Biotransformation), University of Mississippi, USA. Farid has an outstanding academic records of accomplishments towards his University, country, and the African union. Subsequently Prof. Badria was recognized at both national and international levels; Masoura recognition medical award 2006, State Recognition Award in Medicine (Egyptian Academy of Science) 2001, Outstanding Arab Scholar, Kuwait (2000), Khawrazmi International Award, Presented by Iranian President, Iran (2000), Merit of First Class from the President of Egypt (1998), State Recognition Award in Medicine (Egyptian Academy of Science), 1996, Mansoura University Recognition Award in Pharmaceutical sciences(Mansoura University) 1996, Food and Drugs Administration, 1998 (FDA, Arab Development Fund, Kuwait (2000), ICRO-UNESCO International, Chile (1999), UNESCO Biotechnology Fellowship, France (1994), Honorary Fellowship, University of Mississippi, USA (1987-90). Cooperation of Prof. Badria with several African countries was presented in forms of Projects in the area of Nephropathy and mycotoxins (Monasteur, Tunise, with Prof. Hasan Bacha, 1996), Lectures and workshops (Dakar, Sengal, HCV workshop 2005), Algeria (Training, MS. Hewetta, 2009). Prof. Badria utilized his extensive experience in the areas of Chemistry of Natural Products (U. of Mansoura (Egypt), and Mississippi, USA, Biology (U of Minnesota, USA), Molecular biology (U. Mainz, Germany), and Medical and clinical (U. Roma, Italy) to develop potential agents and/or drugs to help fight endemic diseases among African community (e.g Schistosomiasis, Hepatitis, fatty liver, parasites). Over 100 publications, several patents, and many innovative techniques documented the concerted efforts by Prof. Badria to serve Egyptian and international communities. Some of very important accomplishments may be summarized as follows:
- Sixteen Approved patents: Currently 5 products are in the pipelines in Pharmaceutical firms for treatment of: Hepatitis, Schistosomiasis, Colitis, Osteoarthritis.
- Utilization of available natural economic resources: Most of raw materials used in developing new therapeutic agents were obtained from our own natural sources.
- Bridging gaps between University, Industry, and community.
- Emphasizing on the role of research and innovation in improving economy, health, and welfare of society.
